From theheart.org on Medscape

News from the:

European Society of Cardiology (ESC) Congress 2014

August 30 - September 03, 2014; Barcelona, Spain

The Cardiology Show

The Cardiology Show From ESC 2014 with Dr Valentin Fuster UPDATED with Transcript // Focusing on the positive trials from ESC, including PARADIGM HF and ODYSSEY, Dr Fuster and panelists end on the sobering note of poor medication adherence.

Meeting Highlights at a Glance

Top News From ESC 2014: Slideshow Headlines from the world's largest cardiology meeting include promising data on next-generation heart failure and cholesterol drugs.

Conference News

ESC Fewer CRT-Lead-Related Complications With Quadripolar Vs Bipolar Leads: MORE CRT Trial
Heartwire from Medscape, September 12, 2014
ESC WEARIT-II: Wearable Defibrillator Safe, Helps in ICD Decision
Heartwire from Medscape, September 12, 2014
ESC New Revascularization Guidelines Trim Back Bivalirudin, DAPT
Heartwire from Medscape, September 11, 2014
ESC Antihypertensives Up Survival but May Cause Falls in Seniors
Heartwire from Medscape, September 11, 2014
ESC Hypertension up to Six Times More Likely in Obese vs Slim Youth
Heartwire from Medscape, September 10, 2014
ESC Short-Term Amiodarone After AF Ablation Won't Block Late AF
Heartwire from Medscape, September 8, 2014
ESC IMPI: No Immunotherapy Benefit in Tuberculous Pericarditis
Heartwire from Medscape, September 8, 2014
ESC FOCUS: More MI Survivors Adhere to Polypill Than Three Pills
Heartwire from Medscape, September 8, 2014
ESC SYMPLICITY at One Year: Still No BP Benefit vs Controls
Heartwire from Medscape, September 5, 2014
ESC Heart Stop: Subway Stations Among Best AED Sites In Paris
Heartwire from Medscape, September 5, 2014
ESC Iron Therapy Boosts Function, QoL in HF Patients: CONFIRM HF
Heartwire from Medscape, September 4, 2014
ESC Find It, Treat It: 'Lousy' Prognosis for Asymptomatic AF
Heartwire from Medscape, September 4, 2014
ESC TASTE at One Year: No Gains from Thrombectomy in PCI for STEMI
Heartwire from Medscape, September 3, 2014
ESC Beta-Blockers No Use in HF Patients With Atrial Fibrillation
Heartwire from Medscape, September 3, 2014
ESC PARADIGM-HF: Some Say, 'A New Day in Heart Failure'
Heartwire from Medscape, September 2, 2014
ESC BIOSCIENCE: DES With Biodegradable Polymer Matches Comparator
Heartwire from Medscape, September 2, 2014
ESC Rosuvastatin Reduces Plaque Volume in STEMI Patients
Heartwire from Medscape, September 2, 2014
ESC Mechanical Valves in Pregnancy: Scant Progress, Big Risks
Heartwire from Medscape, September 2, 2014

ESC Brilinta Prehospital: No Reperfusion Boost, Less Thrombosis
Heartwire from Medscape, September 2, 2014
ESC X-VERT: Rivaroxaban a Warfarin Alternative in AF Cardioversion
Heartwire from Medscape, September 2, 2014
ESC FAME-2 and FAMOUS: FFR Impressive in Stable CAD and ACS
Heartwire from Medscape, September 1, 2014
ESC More Proof: Renal Denervation Success Needs Total Ablation
Heartwire from Medscape, September 1, 2014
ESC Dramatic Drop in MACE With Complete vs Culprit P-PCI
Heartwire from Medscape, September 1, 2014
ESC Can Beta-Blockers Be Stopped Post-AMI With Preserved LVEF?
Heartwire from Medscape, August 31, 2014
ESC SIGNIFY: No Ivabradine Clinical Outcomes Gain in Stable CAD
Heartwire from Medscape, August 31, 2014
ESC Huge Decreases in LDL Cholesterol With Alirocumab: ODYSSEY
Heartwire from Medscape, August 31, 2014
ESC Colchicine 'Useless' for Postop Pericardial Effusion: POPE-2
Heartwire from Medscape, August 31, 2014
ESC Darapladib No Benefit in ACS Patients: SOLID-TIMI 52
Heartwire from Medscape, August 31, 2014
ESC 15-Year Data Show Better Survival in Elderly AMI Patients
Heartwire from Medscape, August 30, 2014
ESC Highly Sensitive cTnT Safely Rules Out MI in One Hour
Heartwire from Medscape, August 30, 2014
ESC New-Generation DES Match BMS Stent Safety Beyond One Year: SCAAR
Heartwire from Medscape, August 30, 2014
ESC NECTAR-HF Vagal-Nerve Stimulation Study Misses End Points
Heartwire from Medscape, August 30, 2014
ESC COPPS-2: Colchicine Stops Postop Pericarditis, Troubles Gut
Heartwire from Medscape, August 30, 2014
ESC PARADIGM-HF: New Drug Class Outclasses ACE-I in Chronic HF
Heartwire from Medscape, August 30, 2014
ESC What's Going to Be Hot at ESC Congress 2014
Heartwire from Medscape, August 27, 2014

Perspectives from ESC

How to Manage Muscle Pain in Patients on Statins
Eric Bruckert, MD, PhD
Faster, Cheaper, Clinical Trials: Are We There Yet?
Robert A Harrington, MD; Gregg W Stone, MD
Electrophysiology Data From ESC Explained
Neil E. Moat, MBBS, FRCS; Jagmeet P. Singh, MD
NOAC Update on Dosing and Transitioning
Samuel Z. Goldhaber, MD; Christian T. Ruff, MD, MPH
Vagal Nerve Stimulation in HF: Mixed Findings at ESC
Gerhard Hindricks, MD
Lipids Lowdown From ESC: PCSK9 Inhibitors and LDL-C Goals
Michelle L. O'Donoghue, MD, MPH; M. John Chapman, PhD, DSc
Antithrombotics in ACS and TAVR
Neil E. Moat, MBBS, FRCS; Michelle L. O'Donoghue, MD, MPH
ATLANTIC: Prehospital vs Cath Lab Ticagrelor in Primary PCI
Gilles Montalescot, MD, PhD
New and Improved: ESC Guidelines for Pulmonary Embolism
Samuel Z. Goldhaber, MD
A Rapid-Fire Review of Four Big Trials From ESC 2014
Robert A. Harrington, MD; E. Magnus Ohman, MD
PARADIGM-HF: Is It Applicable to US Patients?
Ileana L. Piña, MD, MPH
Will CvLPRIT Change US Primary PCI Guidelines?
Gilles Montalescot, MD, PhD; Anthony H. Gershlick, MBBS

Bloggers From the Floor

'Just-Because' Use of Beta-blockers Questioned at ESC 2014 Dr John Mandrola discusses two presentations that look into the use of beta-blockers in patients with HF and AF and the use of these drugs long after MI.
Finding the Optimal Approach to Ablation of Persistent AF Dr John Mandrola summarizes the STAR AF 2 presentation and points out some other ablation sessions of note.
Seeing the Future of Batteryless Cardiac Devices Dr John Mandrola attends a session where an engineer presents a pacemaker that derives its energy from the heart itself.
Dedicated AF Clinics: There Is No 'I' in TEAM Dr John Mandrola discusses a presentation at ESC where a nurse-led multidisciplinary approach improves AF outcomes as well as enhancements in cost-effectiveness and patient knowledge.
10 Reasons to Like PARADIGM-HF and Four That Warrant Pause Dr John Mandrola sums up the many pluses of the trial but points out some things not to overlook, including treating the patient, not just one disease.
A 43-Year-Old With a Calcium Score of 347: What to Do? Dr Melissa Walton-Shirley reports on a test the audience took at an ESC session on what they'd do with an asymptomatic middle-aged male.
Not All CHA ₂DS ₂-VASc 1s Are Created Equal: No Kidding Dr Melissa Walton-Shirley discusses presentations on the possibly inadequacies of the CHA2DS2-VASc score and the real risk of stroke in untreated AF patients.
CvLPRIT: Validating the Interventionalist's Will to Indulge? Dr Melissa Walton-Shirley's take on CvLPRIT and an ode to interventional cardiologists.
TAVI: What's new? LOTS! Dr Melissa Walton-Shirley reports on a number of TAVI presentations, including discussions of local vs general anesthesia and the Direct Flow TAVI device.
CONFIRM-HF: Changing the Who's Who of IV Iron Therapy Dr Melissa Walton-Shirley discusses the CONFIRM-HF trial and shares the results of IV iron therapy from her family's experiences.

Live Blog

News and Views from ESC 2014 Coverage of key advances and expert reactions as they happened at the meeting.

Previous Coverage